Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Pharmacol Rev. 2013 Aug 1;65(4):1148-61. doi: 10.1124/pr.113.007823. Print 2013.
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that belongs to the family of basic helix-loop-helix transcription factors. Although the AhR was initially recognized as the receptor mediating the pathologic effects of dioxins and other pollutants, the activation of AhR by endogenous and environmental factors has important physiologic effects, including the regulation of the immune response. Thus, the AhR provides a molecular pathway through which environmental factors modulate the immune response in health and disease. In this review, we discuss the role of AhR in the regulation of the immune response, the source and chemical nature of AhR ligands, factors controlling production and degradation of AhR ligands, and the potential to target the AhR for therapeutic immunomodulation.
芳香烃受体 (AhR) 是一种配体激活的转录因子,属于碱性螺旋-环-螺旋转录因子家族。尽管 AhR 最初被认为是介导二恶英和其他污染物病理作用的受体,但内源性和环境因素激活 AhR 具有重要的生理作用,包括调节免疫反应。因此,AhR 提供了一种分子途径,通过该途径,环境因素可以调节健康和疾病中的免疫反应。在这篇综述中,我们讨论了 AhR 在调节免疫反应中的作用、AhR 配体的来源和化学性质、控制 AhR 配体产生和降解的因素,以及针对 AhR 进行治疗性免疫调节的潜力。